 and we will have a presentation by Katri Avelolo. She's the head of our national focal point in Estonia. She, this is the National Institute for Health Development and they started even more recently with their take-home Naloxone project for good reason. So, and you will go and say something about this. Good afternoon. I promise I will be very short. The first slide is the background information why we needed Naloxone program in Estonia. As you heard today already that we have the highest drug-related death rate in EU and here are the drug-related death cases since 2008 and most of them are related with the synthetic opioid fentanyl. And to reduce the drug-related death rate then a National Institute for Health Development launched the take-home Naloxone program in September 2013. And right now the program operates in two regions, East Viruma, what is next to Russian border and Hariuma, what is the region of capital city. And the program basically is about educating IDUs to recognize the overdose and then administrate Naloxone and the third point is to give the first aid until the ambulance arrives. The provision of services carried out in cooperation with local healthcare providers and the harm reduction services operating in the region. The problem is that the only healthcare provider who is professional healthcare provider can prescribe Naloxone. So the National Institute for Health Development trains the professional healthcare provider to train the drug users and their close ones and after they have completed the training then they will give out Naloxone-filled assurances to them. And also Naloxone is not available in any pharmacy but the only pharmacy is what have contract with Health National Institute for Health Development. And the role of harm reduction services is to motivate the customers to participate in the training and also they form the training groups. We have service description what is adopted by the director of the National Institute and it states how to carry out the training and how to put together the training groups. The points here are what the, this is the knowledge what should be received during the trainings. The first point is drugs and their effects and also they discuss interactions between different drugs, then how overdose occurs, then giving first aid to someone who has overdosed, then they teach how to use pre-filled Naloxone-surances. Then there is a section about the infectious disease prevention because they deal with needles also. And the last part is maintaining the use of Naloxone-surances, what to do if they use it and where they will get the new one. And this training is valid for three years. After three years they have to retake the training course if they want to participate in the program. Inclusion criteria is you have to be at least 16 years old. The service is not anonymous, you have to identify yourself and you have to have the risk of opioid overdose. Then drug users can appoint their personal pair or someone close to them to participate in the program. And also it's provided for the Metadone Substitution Therapy Service providers and health care providers working within the harm reduction services, basically the insurance exchange points. The program is very well monitored. All the persons participating in the program are documented and also every needle what is used is documented and also discussed with the Harm Reduction Service personnel. This is the visual site of our Naloxone kit. We used the similar as it was in Scotland. It's Prenoxade injection. It contains two milliliters of Naloxone hydrochloride and two needles. And also we provide information materials. One is about Naloxone and one is how you act in case of overdose. There is a precise description how you deal with that. First results of Estonian Pilot Project are here. So totally we have given out 552 Naloxone kits and 554 people have participated in the trainings. And we know that we have had 72 repeated prescriptions. And we know that 71 of them actually have been used on purpose that actually some lives were saved. One was like just lost or I don't remember anymore. And just to finalize like I mentioned that the program has been offered in two regions. Probably we should expand the service because there is an increasing interest. Our injecting drug users are quite interested in because of the fentanyl they really like to save their lives. And also police is right now one target group like the Scottish colleague mentioned that we also would like to have in the future the situation where the Naloxone is part of the police emergency kit. Thank you.